ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Breast12, CAPItello-290, and ICARUS-BREAST01 | VuMedi

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Breast12, CAPItello-290, and ICARUS-BREAST01

By 2024 ESMO Annual Meeting Insights Hub FEATURING Sara Tolaney, Hope Rugo

By 2024 ESMO Annual Meeting Insights Hub FEATURING Sara Tolaney, Hope Rugo

517 views

October 4, 2024

DESTINY-Breast12: Efficacy in Brain Metastases

00:00

T-DXd's Impact & Treatment Considerations

03:02

Managing T-DXd Side Effects & Steroid Use

05:14

Exploring ADCs in HER2-Low Breast Cancer

08:02

CAPItello-290: AKT Inhibitor in Triple Negative BC

09:50

Challenges in Targeting Biomarkers in TNBC

09:54

ICARUS-BREAST01: HER3-DXd in HR+ Breast Cancer

14:47

Future of ADCs & HER3-DXd's Place

16:48

Comments 0

Login to view comments. Click here to Login